Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?
- PMID: 30151691
- PMCID: PMC6246795
- DOI: 10.1007/s10286-018-0556-5
Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?
Keywords: Autonomic nervous system diseases; Hypertension; Orthostatic hypotension.
Conflict of interest statement
Conflict of interest
M.C.F. and A.S.B. have no conflicts of interest to declare. C.A.S. has received a research grant from Doris Duke Foundation. C.A.S. received grant support from Office of Orphan Products Development. Food and Drug Administration, Grant #FD-R-04778–01-A3. C.A.S. has received speaker honorarium from Lundbeck Pharmaceuticals. C.A.S. received consulting honoraria from Lundbeck and Theravance Biopharma. C.A.S is member of the Board for the American Autonomic Society.
Figures
References
-
- Sharabi Y, Dendi R, Holmes C, Goldstein DS (2003) Baroreflex Failure as a Late Sequela of Neck Irradiation. Hypertension 42:110–116 - PubMed
-
- Heusser K, Tank J, Luft FC, Jordan J (2005) Baroreflex Failure. Hypertension 45:834–839 - PubMed
-
- Iodice V, Kimpinski K, Vernino S, Sandroni P, Low PA (2009) Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci 146:22–25. - PubMed
-
- Gibbons CH, Vernino SA, Kaufmann H, Freeman R (2005) l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy: Neurology 65:1104–1106 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
